Procaps Group, S.A Return on Investment 2020-2023 | PROCF

Current and historical return on investment (ROI) values for Procaps Group, S.A (PROCF) over the last 10 years.
Procaps Group, S.A ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2023-09-30 $0.03B $0.26B 20.53%
2023-06-30 $0.04B $0.20B 27.21%
2023-03-31 $0.04B $0.16B 32.39%
2022-12-31 $0.04B $0.03B 31.97%
2022-09-30 $0.07B $0.16B 48.59%
2022-06-30 $0.07B $0.15B 50.17%
2022-03-31 $0.07B $0.15B 65.75%
2021-12-31 $0.07B $0.14B 96.89%
2021-09-30 $0.29B $0.15B 465.04%
2021-06-30 $0.28B 1162.89%
2021-03-31 $0.27B 1096.91%
2020-12-31 $0.27B $0.10B 1096.91%
2020-09-30 $0.01B inf%
2019-12-31 $0.00B nan%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.125B $0.410B
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Stock Name Country Market Cap PE Ratio
NextEra Energy Partners, LP (XIFR) United States $0.828B 4.49